1 | ATROPINE EYE DROPS BP | Composition : | |
| | Atropine Sulphate IP | 1 % w/v |
| | Aqueous buffer vehicle | q.s |
2 | ATROPINE EYE DROPS USP | Composition : | |
| | Atropine Sulphate IP | 0.5%w/v |
| | Aqueous buffer vehicle | q.s |
3 | BETAMETHASONE SODIUM PHOSPHATE | Composition : | |
| & NEOMYCIN SULFATE EYE/EAR DROPS | Betamethsone Sodium Phosphate USP | 0.1w/v |
| | Neomycin sulfate USP | 0.5w/v |
| | Aqueous buffer vehicle | q.s |
4 | CARBOXY METHYL | Composition : | |
| CELLULOSE SODIUM EYE/EAR DROP | Carboxymethyl Cellulose Sodium IP | 0.5%w/v |
| | Aqueous buffer vehicle | q.s |
5 | CHLORAMPHENICOL, CLOTRIMAZOLE, | Composition : | |
| BECLOMETHASONE & LIGNOCAINE EAR DROP | Chloramphenicol IP | 0.5 %w/v |
| | Clotrimazole IP | 1%w/v |
| | Beclomethasone Dipropionate IP | 0.025%w/v |
| | Lignocaine Hydrochloride IP | 2 %w/v |
| | In a sterile aqueous base | q.s |
6 | CHLORAMPHENICOL & BETAMETHASONE SODIUM | Composition : | |
| PHOSPHATE EYE/EAR DROP | Chloramphenicol IP | 1%w/v |
| | Betamethasone Sodium Phosphate IP | 0.1%w/v |
| | Aqueous buffer vehicle | |
7 | CHLORAMPHENICOL EAR DROP | Composition : | |
| | Chloramphenicol IP | 5%w/v |
| | Aqueous buffer vehicle | q.s |
8 | CIPROFLOXACIN & BETAMETHASONE | Composition : | |
| EYE/EAR DROPS | Ciprofloxacin Hydrochloride IP | |
| | Equ. To Ciprofloxacin | 0.3%w/v |
| | Betamethasone IP | 0.05%w/v |
| | Sterile Aqueous base | q.s |
9 | CIPROFLOXACIN, BETAMETHASONE EYE/EAR DROPS | Composition : | |
| | Ciprofloxacin Hydrochloride IP | |
| | Equ. To Ciprofloxacin | 0.3%w/v |
| | Betamethasone IP | 0.1%w/v |
| | Sterile Aqueous base | q.s |
10 | CIPROFLOXACIN & DEXAMETHASONE | Composition : | |
| EYE DROPS | Ciprofloxacin Hydrochloride BP | |
| | Equ. To Ciprofloxacin | 0.3%w/v |
| | Dexamethasone BP | 0.01 %w/v |
| | Aqueous buffer vehicle | q.s |
11 | CIPROFLOXACIN EYE DROP IP | Composition : | |
| | Ciprofloxacin hydrochloride IP | |
| | Equ. To Ciprofloxacin | 0.3%w/v |
| | Aqueous buffer vehicle | q.s |
12 | CLOTRIMAZOLE EAR DROPS | Composition : | |
| | Clotrimazole IP | 1 % w/v |
| | Aqueous buffer vehicle | q.s |
13 | DEXAMETHASONE SODIUM PHOSPHATE EYE/EAR DROPS BP | Composition : | |
| | Dexamethasone Sodium Phosphate IP | 0.1 % w/v |
| | Aqueous buffer vehicle | q.s |
14 | GENTAMICIN SULPHAT EYE DROP IP | Composition : | |
| | Gentamicin sulphate IP | |
| | Equ.to Gentamicin | 0.3%w/v |
| | Benzalkonium chloride IP | 0.02%v/v |
| | (As preservative) | |
| | Aqueous buffer vehicle | Qs |
15 | GENTAMICIN SULPHATE & BETAMETHASONE | Composition : | |
| SODIUM PHOSPHATE EAR DROPS | Gentamicin Sulphate IP | |
| | Equ.to Gentamicin | 0.3%w/v |
| | Betamethasone Sodium Phosphate IP | 0.1%w/v |
| | Aqueous buffer vehicle | q.s |
16 | GENTAMICIN & DEXAMETHASONE | Composition : | |
| SODIUM PHOSPHATE EYE DROPS | Gentamicin sulfate BP | |
| | Equ.to Gentamicin | 0.3%w/v |
| | Dexamethasone Sodium Phosphate BP | 0.1%w/v |
| | Aqueous buffer vehicle | q.s |
17 | HYDROXY PROPYL CELLULOSE, BORAX, BORIC | Composition: | |
| ACID, SODIUM CHLORIDE, POTASSIUM CHLORIDE, | Hydroxy Propyl Cellulose IP | 0.7%w/v |
| MENTHOL, ZINC SULPHATE EYE DROPS | Borax BP | 0.19%w/v |
| | Boric Acid IP | 0.19%w/v |
| | Sodium Chloride IP | 0.45%w/v |
| | Potassium Chloride IP | 0.37%w/v |
| | Menthol IP | 0.005%w/v |
| | Zinc Sulphate IP | 0.004%w/v |
| | Benzalkonium Chloride IP | |
| | ( As Preservative ) | |
| | Sterile Aqueous base | q.s |
18 | HYDROXY PROPYL METHYL | Composition : | |
| CELLULOSE EYE DROPS | Hydroxy Propyl Methyl Cellulose IP | 0.5%w/v |
| | Aqueous buffer vehicle | q.s |
19 | NAPHAZOLINE HCl, CHLORPHENIRAMINE | Composition : | |
| MALEATE & ZINC SULPHATE EYE DROPS | Naphazoline Hydrochloride BP | 0.05%w/v |
| | Chlorpheniramine Maleate IP | 0.01%w/v |
| | Zinc Sulphate IP | 0.12%w/v |
| | Aqueous buffer vehicle | q.s |
20 | | Composition: | |
| Xylometazoline Hydrocloride Nasal Drops IP | Xylometazoline Hydrocloride IP | 0.5 %w/v |
| | Aqueous buffer vehicle | q.s |
21 | OFLOXACIN & BETAMETHASONE SODIUM | Composition : | |
| PHOSPHATE EYE/EAR DROP | Ofloxacin IP | 0.3%w/v |
| | Betamethasone Sodium Phosphate IP | 0.1%w/v |
| | Aqueous buffer vehicle | |
22 | OFLOXACIN & DEXAMETHASONE | Composition : | |
| SODIUM PHOSPHATE EYE/EAR DROP | Ofloxacin IP | 0.3%w/v |
| | Dexamethasone sodium | |
| | Phosphate IP | 0.05 %w/v |
| | Aqueous buffer vehicle | q.s |
23 | OXYMETAZOLIN HCL NASAL DROPS | Composition : | |
| | Oxymetazolin HCl | 0.025%w/v |
| | Aqueous buffer vehicle | q.s |
24 | OXYMETAZOLIN HCL NASAL DROPS | Composition : | |
| | Oxymetazolin HCl | 0.05%w/v |
| | Aqueous buffer vehicle | q.s |
25 | OFLOXACIN & BETAMETHASONE | Composition : | |
| SODIUM PHOSPHATE EYE/EAR DROPS | Ofloxacin IP | 0.3 %w/v |
| | Betamethasone Sodium Phosphate IP | 0.05%w/v |
| | Sterile Aqueous base | q.s |
26 | OFLOXACIN OPHTHALMIC SOLUTION IP | Composition : | |
| | Ofloxacin IP | 0.3 %w/v |
| | Beta-cyclodextrin BP | 0.1%w/v |
| | Benzalkonium Chloride IP | 0.02%w/v |
| | (As preservative) | |
| | Aqueous buffer vehicle | q.s |
27 | PHENYLEPHRINE HCl, MENTHOL, CAMPHOR, | Composition : | |
| CHLORPHENIRAMINE MALEATE EYE DROPS | Phenylephrine Hydrochloride IP | 0.12%w/v |
| | Menthol IP | 0.005%w/v |
| | Camphor IP | 0.01%w/v |
| | Chlorpheniramine Maleate IP | 0.1%w/v |
| | Benzalkonium Chloride Solution IP | 0.01%w/v |
| | (As Preservative) | |
| | Sterile Aqueous base | q.s |
28 | PREDNISOLONE SODIUM PHOSPHATE EYE DROPS BP | Composition : | |
| | Prednisolone Sodium Phosphate BP | 1.0 %w/v |
| | Aqueous buffer vehicle | q.s |
29 | SODIUM CHLORIDE NASAL DROPS | Composition : | |
| | Sodium Chloride IP | 0.65 % w/v |
| | Aqueous buffer vehicle | q.s |
30 | SULPHACETAMIDE SODIUM EYE DROP IP | Composition : | |
| | Sulphacetamide Sodium IP | 30%w/v |
| | Aqueous buffer vehicle | q.s |
31 | SULPHACETAMIDE SODIUM EYE DROP IP | Composition : | |
| | Sulphacetamide Sodium IP | 10%w/v |
| | Aqueous buffer vehicle | q.s |
32 | SULPHACETAMIDE SODIUM EYE DROP IP | Composition : | |
| | Sulphacetamide Sodium IP | 20%w/v |
| | Aqueous buffer vehicle | q.s |
33 | SODIUM CARBOXYMETHYLCELLULOSE & | Composition : | |
| GLYCERINE EYE/EAR DROPS | Sodium Carboxymethylcellulose IP | 0.5%w/v |
| | Glycerine IP | 0.5%w/v |
| | Stabilized Oxychloro Complex ( As Preservative) | 0.1%w/v |
| | Aqueous buffer vehicle | q.s |
34 | SODIUM CARBOXYMETHYL CELLULOSE EYE DROP IP | Composition : | |
| | Sodium Carboxymethyl Cellulose IP | 0.5%w/v |
| | Aqueous buffer vehicle | q.s |
35 | SODIUM CARBOXYMETHYL CELLULOSE | Composition : | |
| EYE DROPS | Sodium Carboxymethyl Cellulose IP | 1%w/v |
| | Aqueous buffer vehicle | q.s |
36 | TIMOLOL EYE DROPS IP | Composition : | |
| | Timolol Maleate IP | |
| | Equ. To Timolol | 0.25%w/v |
| | Aqueous buffer vehicle | q.s |
37 | TIMOLOL MALEATE EYE DROPS IP | Composition : | |
| | Timolol Maleate IP | |
| | Equ. To Timolol | 0.5 % w/v |
38 | TURPENTINE OIL, CHLORBUTOL, BENZOCAINE | Composition: | |
| & PARADICHLOROBENZENE EAR DROPS | Turpentine Oil BP | 15 % w/v |
| | Chlorbutol IP | 5 % w/v |
| | Benzocaine IP | 2.7 % w/v |
| | Paradichlorobenzene | 2 % w/v |
| | Oil base | q.s |